Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 19k
12 July 2019
E-002237-19
Question for written answer E-002237-19
to the Commission
Rule 130
João Ferreira (GUE/NGL)

 Subject:  Air transport of medicines to the Outermost Regions (ORs)
 Answer in writing 

In the Autonomous Region of Madeira, there has been a recurrent failure to comply with provisions regarding the dispensing, within a maximum period (12 hours), of medicines that are sold out in pharmacies, but not in the distribution chain. In the case of medicines sold out in the distribution chain, due diligence is required in order to obtain supplies from distributors or manufacturers.

Due to logistical constraints related to the transport of cargo by air, in critical situations where it has been established that medicines are out of stock, measures are urgently needed to ensure that the transport of medicines by air enjoys effective priority.

These transport — particularly air transport — needs between the islands of the outermost regions, such as Madeira, could be adequately met with the help of specific measures within the context of EU Cohesion Policy.

1. What measures and instruments are available and could be used at EU level to support the delivery of this important public service so as to prevent the inhabitants of these regions potentially running the risk of not having access to the treatment to which they are entitled?

2. What further measures are envisaged to reduce the extra costs arising from the outermost status of the regions concerned and to help the ORs address the increased problems of access to medicines they face?

Original language of question: PT 
Last updated: 26 July 2019Legal notice